Business programme

Gene Therapy: Embarking on the Future Today

17 Jun , 10:00–11:15
International Youth Economic Forum
Pavilion G, conference hall G4

The advancement of cutting-edge, state-of-the-art therapeutic solutions stands as a highly sought-after field in the realm of biomedicine. Across the globe, hundreds of clinical trials are currently underway, assessing the safety and effectiveness of gene therapy products for combating severe inherited ailments including haemophilia, spinal muscular atrophy, Duchenne muscular dystrophy, various visual impairments, and lysosomal storage diseases, among others. Notably, several medications have already made their way into the market, while numerous other products showcase remarkable efficacy in addressing conditions that were previously deemed either incurable or arduous to treat. Are there any noteworthy scientific research endeavours taking place in the Russian Federation regarding the development of advanced therapy products, and how close are we to their implementation in clinical practice? Have Russian developers gained expertise in producing genetically modified biomedical cell products and oncolytic viruses? Are we capable of rivalling the world's leading bioengineering laboratories in terms of creating groundbreaking drugs for gene therapy? And, above all, how can we collaborate and support each other in achieving these ambitious yet highly coveted objectives?

Roman Ivanov, Director of the Scientific Center for Translational Medicine, Vice-Rector for Scientific and Technological Development, Sirius University of Science and Technology

Tatyana Egorova, Head of Gene Therapy Laboratory, Marlin Biotech; Researcher, Laboratory for Modeling and Therapy of Hereditary Diseases, Institute of Gene Biology of the Russian Academy of Sciences
Ilyas Esmagambetov, Head of the Laboratory of Stromal Regulation of Immunity, National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamalei
Alexander Karabelsky, Head of Gene Therapy Direction, Sirius University of Science and Technology
Alexander Malogolovkin, Head of Molecular Virology Laboratory, Sechenov University
Vadim Merkulov, Deputy Director General for Drug Expertise, Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation (online)
Vladimir Richter, Head of the Laboratory of Biotechnology, Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences